LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Moderna Inc

Moderna Inc

Deschisă

Sector Sănătate

69.77 2.24

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

67.94

Maxim

70.55

Indicatori cheie
By Trading Economics
Venit	-104M -1.3B
Vânzări	-167B 241M
P/E Medie Sector	35.86 103.001
EPS	-3.33
Marjă de profit	-530.705
Angajați	5,600
EBITDA	-109M -1.2B

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+54.51 upside

Dividende
By Dow Jones
Următoarele câștiguri	31 oct. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	-65M 30B
Deschiderea anterioară	67.53
Închiderea anterioară	69.77

Sentimentul știrilor

By Acuity

59%

41%

284 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

64.1101 / 73.44 Suport & Rezistență

Moderna Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 dec. 2023, 13:16 UTC

Principalele dinamici ale pieței

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

14 oct. 2023, 00:02 UTC

Acțiuni populare

Stocks to Watch: Pfizer, Moderna, Lululemon Athletica

15 sept. 2024, 07:00 UTC

Top știri

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

12 sept. 2024, 15:02 UTC

Top știri

Moderna Cost Cuts Fail to Restore Investor Trust -- Heard on the Street -- WSJ

12 sept. 2024, 10:00 UTC

Top știri

Moderna Pulls Back on R&D and Delays Timeline for Profitability -- Barrons.com

6 sept. 2024, 11:00 UTC

Top știri

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept. 2024, 04:00 UTC

Top știri

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23 aug. 2024, 18:38 UTC

Top știri

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2 aug. 2024, 21:29 UTC

Top știri

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1 aug. 2024, 10:30 UTC

Top știri

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3 iul. 2024, 14:18 UTC

Achiziții, Fuziuni, Preluări

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30 mai 2024, 19:45 UTC

Top știri

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29 mai 2024, 15:56 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10 mai 2024, 20:11 UTC

Câștiguri

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Câștiguri

Acțiuni populare

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2 mai 2024, 13:46 UTC

Câștiguri

Acțiuni populare

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2 mai 2024, 10:31 UTC

Câștiguri

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2 mai 2024, 09:08 UTC

Acțiuni populare

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28 feb. 2024, 14:14 UTC

Câștiguri

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22 feb. 2024, 16:00 UTC

Top știri

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22 feb. 2024, 12:40 UTC

Câștiguri

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

2 nov. 2023, 16:53 UTC

Câștiguri

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat -- IBD

2 nov. 2023, 08:58 UTC

Câștiguri

These Stocks Are Moving the Most Today: Qualcomm, PayPal, SolarEdge, Roku, DoorDash, E.l.f. Beauty, and More -- Barrons.com

31 oct. 2023, 16:35 UTC

Top știri

Câștiguri

Nevermind Covid, Investors Want a Pfizer Obesity Pill -- Heard on the Street -- WSJ

17 oct. 2023, 10:00 UTC

Top știri

Pfizer Looks for a Covid Bottom -- Heard on the Street -- WSJ

26 sept. 2023, 09:30 UTC

Top știri

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out -- WSJ

Comparație

Modificare preț

Moderna Inc Așteptări

Obiectiv de preț

By TipRanks

54.51% sus

Prognoză pe 12 luni

Medie 105.5 USD 54.51%

Maxim 238 USD

Minim 46 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruModerna Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

18 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 18 analiști care au acordat evaluări ale acțiunilor Moderna Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

64.1101 / 73.44Suport & Rezistență

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

284 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.